(Press-News.org) Dr. Joseph Glavy at Stevens Institute of Technology studies the smallest and most basic elements of life. The Assistant Professor of Chemical Biology runs the Glavy Lab, where advanced student scientists study the nuclear pore complexes (NPCs) in cells, observing the minutest mechanisms of life as they unfold during mitosis. The Glavy Lab's formal purpose is to study the NPC at the molecular level in the pursuit of the unknown or unexpected in the well-studied but not always well-understood nuclei of living cells.
His team has uncovered a disease-related protein outside of its known range and published the results in the August 2010 issue of Cell Cycle. The article's co-authors, Dr. Simarna Kaur, Tommy White, and Amanda DiGuilio are current or recent students of Stevens Institute of Technology.
The NPC is a supramolecular assembly that provides gateways for molecular trafficking between DNA with a cell's nucleus and the cytoplasm within the cell membrane walls in eukaryotic cells. Protein, RNA, ions, and other small molecules are transported through the NPC on their way into the nucleus. The composition of the NPC is about thirty proteins, called nucleoporins (Nups), which are arranged quasi-symmetrically and in subcomplexes that break apart during mitosis in some cells.
Dr. Glavy investigated interactions within the NPC of mammalian cells while a post-doctoral researcher at Rockefeller University in New York City. Unlike other living cells, the mammalian cell NPC breaks down around DNA during mitosis, allowing specific Nup subcomplexes to be isolated and studied in the lab, but also leaving room for something to go wrong in the reorganization of the nucleus . Focused on the very specific Nup 107-160 subcomplex, the Glavy Lab had been looking for what might go wrong during mitosis.
But rather than genetic mutations, the lab discovered something far more important within Nup 107-160: the Werner Helicase Interacting Protein 1 (WHIP). WHIP's moniker derives from its interaction with Werner protein, which maintains genome stability and conversely is responsible for the progeria disease Werner's Syndrome. This adult-onset disease causes premature aging and increased susceptibility to other old-age diseases such as cancer, heart disease, and diabetes.
The initial discovery of WHIP within the NPC, when it had been associated with the Werner protein, prompted further exploration to deduce the role of WHIP during mitosis. The scientists isolated the NPC subcomplex and used immunofluorescence and immunoblotting to detect the presence and movement of WHIP during mitosis. They discovered WHIP interacting within the NPC autonomous of Werner protein, demonstrating a novel relation.
In addition to its connection with gene-stabilizing Werner protein, WHIP may play an independent, unique role in the cell cycle. Beyond supporting DNA replication, WHIP may also function to detect genetic damage. The authors look forward to future work that will further understanding of this protein's role in maintaining genome stability, and in completing some of that important work themselves.
It may be years before the Glavy Lab's insights into WHIP can be turned into therapies for sufferers of Werner Syndrome and other progeria diseases, but this new look into the workings of the body creates hope for future treatments and other advances in biology and medicine.
"Cell biology is a growing, multi-disciplinary field that is establishing a foundation of knowledge for the future," says Dr. Glavy. "We are beginning to establish tangible relations between biology and disease and advancing towards an understanding of gene repair and expression that might help with drug development in the future."
INFORMATION:
For the full story on this research and to learn more about the Glavy Lab student research team at Stevens Institute of Technology, The Innovation University (TM), please visit the Stevens Research Blog: http://research.stevens.edu/index.php/glavy-lab-progeria-discovery
END
A new study revealed that the novel self-expanding super-elastic all-metal endoprosthesis stent (SESAME StentTM) used in patients undergoing angioplasty of degenerated saphenous vein graft (SVG) lesions has 100% acute success, low 30 day major adverse cardiac events (MACE) rates, and 9-month patency comparable to balloon expandable stents without embolic protection. Results of the study are published in the November issue of Catheterization and Cardiovascular Intervention, a peer-reviewed journal from The Society for Cardiovascular Angiography and Interventions.
Percutaneous ...
Two essential genes that control the accumulation and detoxification of arsenic in plant cells have been identified. This discovery is the fruit of an international collaboration involving laboratories in Switzerland, South Korea and the United States, with the participation of members of the National Centre of Competence in Research (NCCR) Plant Survival. The results presented are a promising basis for reducing the accumulation of arsenic in crops from regions in Asia that are polluted by this toxic metalloid, as well as for the cleanup of soils contaminated by heavy metals. ...
Scientists are learning more about how protein gets in the urine when the kidneys begin to fail and how a new drug blocks it.
"We have known for a long time that renal failure comes with protein in your urine, especially in diabetes," said Dr. David Pollock, renal physiologist at the Medical College of Georgia Vascular Biology Center. It's also known that a new class of drugs called endothelin A receptor antagonists reduce protein in the urine.
New research published in the journal Hypertension connects the two, providing more information about how new drugs under study ...
WASHINGTON — The United States is missing significant opportunities to reduce traffic fatalities and injuries, and could save lives by implementing a more rigorous, comprehensive program that adopts successful safety practices from other countries, says a new report by the National Research Council.
The committee that wrote the report reviewed traffic safety practices and strategies in high-income countries around the world and compared them with those in the United States. From 1995 to 2009, fatalities dropped 52 percent in France, 38 percent in the United Kingdom, ...
INDIANAPOLIS – Failure to have a prescription filled can undermine medical treatment, result in increased health care costs and potentially have devastating results for the patient. An editorial in the Nov. 16 issue of the Annals of Internal Medicine highlights the problem and issues a call to action.
In the editorial, "Prescription Abandonment: Another Path to Medication Nonadherence," Michael D. Murray, PharmD, MPH, a Regenstrief Institute, Inc. investigator and Purdue University professor of pharmacy practice, and Jeff Harrison, Ph.D., of the University of Auckland, ...
Montreal, November 16, 2010 – Disadvantaged kids are more likely to drop out of high school, become premature parents and raise their own children in poverty, according to an exhaustive new study from researchers at Concordia University and the University of Ottawa.
Published in the International Journal of Behavioral Development, the investigation was the first to follow boys and girls over three decades to examine whether childhood aggression, social withdrawal and low socio-economic status could impact adult wellbeing.
"Low socioeconomic status appears to have ...
A new study from the Swedish medical university Karolinska Institutet shows that asthma drugs are a potential treatment for aortic aneurysm. These drugs, which block cysteinyl-leukotrienes, could reduce the break down of vessel wall tissue and the dilation of the aortic wall, and thus the risk of its rupturing. This could both save lives and reduce the need for complicated and risky surgery. The results are presented in the scientific journal PNAS.
Aortic aneurism is a life-threatening disease caused by the weakening of a section of the wall of the aorta, which then ...
HealthSpace, the internet-accessible personal health organiser developed as part of the National Programme for IT in the National Health Service, was significantly less popular than anticipated, a research team from the University of London has found.
Instead of the predicted 5-10% of the population signing up, only 0.13% of those invited got as far as activating the full functionality of their personal health record, according to the study published on bmj.com today.
Professor Trisha Greenhalgh from Barts and the London School of Medicine and Dentistry led the team ...
Researchers from the Group of Applied Artificial Intelligence (GIAA) on the Colmenarejo Campus of UC3M have presented this application at the latest Salón Internacional de Material Eléctrico y Electrónico, recently held in Madrid. The participants at the stand of Infaimon, the company which has collaborated on this project, had the opportunity to test this interface with a videogame operated simply by moving ones hands as if holding a virtual steering wheel. For this purpose, the scientists have employed a time of flight camera or TOF with which they capture in 3D user's ...
An open letter from 20 consultants and a patient group published on bmj.com today, calls on the prime minister to take action over a legal loophole that allows drug companies to make easy profits by licensing existing treatments for rare (orphan) diseases.
They argue that the current situation concerning orphan drugs is not in the best interests of patients or the NHS and that the cost to the NHS is likely to be above £10m a year.
The original purpose of this legislation was to encourage drug companies to conduct research into rare diseases and develop new treatments. ...
